Investing Profile

Adam Goulburn

InvestorVCFounder

Co-Founder at Dimension

dimensioncap.comNew York, New York

Your Intro Paths to Adam Goulburn

Signal uses Gmail to reveal intro paths. Email content is never read.

Networks Adam is a member of

Howcast Network

391 CONNECTIONS

Autotrac - OmniTracks Network

94 CONNECTIONS

UNSW Australia Network

53 CONNECTIONS

Monash University Network

42 CONNECTIONS

Lux Capital Network

34 CONNECTIONS

Find Adam Goulburn on

Current Investing Position

6 Dimensions Capital

Investment Range

$1M - $3.0M

Sweet Spot

$2.0M

Investments On Record

Current Fund Size

$1.5B

Adam Goulburn is on these Sector & Stage Rankings

BioTech (Series B)Data Services (Series B)Data Services (Seed)Data Services (Series A)BioTech (Seed)BioTech (Series A)Health IT (Series A)Health & Hospital Services (Series B)New York City Health & Hospital Services (Series A)Health IT (Seed)Health IT (Series B)Health & Hospital Services (Seed)Consumer Health (Series B)Consumer Health (Seed)Digital Health (Seed)Digital Health (Series B)Digital Health (Series A)Consumer Health (Series A)

Adam Goulburn's Investments On Record (14)

Company	StageDateRound Size	Total Raised
Eikon Therapeutics	Series DFeb 2025$350M Series BJan 2022$520M Series AMay 2021$150M SeedJan 2019	$1B
Co-investors: Elena Viboch (General Catalyst), Josh Wolfe (Lux Capital), Larry Lasky (The Column Group), Leon Chen (The Column Group), Eric Schmidt (Innovation Endeavors), Dror Berman (Innovation Endeavors)
Kaleidoscope	SeedSep 2022$6M	$22M
Co-investors: Justin Kaufenberg (Rally Ventures), Jeff Hinck (El Dorado Ventures), Daren Cotter (Personal mini family office), Chris Gibson (6 Dimensions Capital), Pablo Lubroth (Enveda), Nitesh Banta (Getaround)
Rivet	Series BJun 2022$21M Series AMar 2020$8M	$34M
Co-investors: Jackson Moses (Afore Capital), Croom Beatty (Menlo Ventures), Chad Packard (Pelion Venture Partners), Gale Wilkinson (Vitalize Venture Capital), Newth Morris (Ankona Capital), Steven Miller (Origin Ventures), Aaron Epstein (Y Combinator), Andreas Klinger (Remote First Capital), Renata Quintini (Renegade Partners)
Plexium	Series BFeb 2022$100M Series AJan 2021$35M	$170M
Co-investors: Josh Wolfe (Lux Capital), Rob Hopfner (Pivotal Life Sciences), Tim Kutzkey (The Column Group), Kiersten Stead (DCVC Bio)
Gandeeva Therapeutics	Series AJan 2022$40M	$40M
Science 37	Post Ipo EquityOct 2021$200M Series UnknownAug 2020$40M	$310M
Co-investors: Krishna Yeshwant (GV (Google Ventures))
AllStripes	Series BAug 2021$50M Series AApr 2020$14M SeedAug 2018$3M	$67M
Co-investors: Nabeel Hyatt (Spark Capital), Deena Shakir (Lux Capital), Peter Bordes (Trajectory Ventures), Anarghya Vardhana (Maveron), Nikhil Basu Trivedi (Footwork), Alice Zhang (Princeton University Investment Company)
Adimab	Series UnknownJan 2020	$41M
Co-investors: Peter Hebert (Lux Capital), Terry McGuire (Polaris Partners), Carl Gordon (OrbiMed Advisors)

Adam Goulburn's Experience

Co-Founder Dimension2022 - Present

Founding CEO HowcastPresent

Founding CEO Autotrac - OmniTracksPresent

Post-Doctoral Associate Weill Cornell MedicinePresent

Venture Partner Lux Capital2022 - 2022

Partner Lux Capital2015 - 2022

Founding CEO VNV Bio (now Aera Therapeutics)2018 - 2021

Founding CEO Kallyope2014 - 2015

Principal Lux Capital2014 - 2015

Senior Associate Lux Capital2012 - 2014

Associate Lux Capital2011 - 2012

Post-Doctoral Associate Weill Cornell Medical College2010 - 2011

Adam Goulburn's Education

Monash University PhD Stem Cell Research

University of New South Wales Bachelor of Commerce / Bachelor of Science International Business, Accounting, Biotechnology

UNSW Australia Bachelor of Commerce / Bachelor of Science International Business, Accounting, Biotechnology

Investors who invest with Adam Goulburn

Scouts & Angels Affiliated With Adam Goulburn